FDA Adverse Event Malfunction Summary report: N

INTERMATE

MDR report key: 3013205 · Received March 20, 2013

Report

Report Number
1416980-2013-06718
Event Type
Malfunction
Date Received
March 20, 2013
Date of Event
February 1, 2013
Report Date
February 25, 2013
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
FRN
PMA / PMN Number
K910425
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE CONTAINING APPROXIMATELY 23ML OF SOLUTION IN THE RESERVOIR. THE REPORTED CONDITION OF NO FLOW/NON-DELIVERY WAS NOT CONFIRMED. VISUAL EXAMINATION OF THE DEVICE SHOWED NO SIGNS OF BLOCKAGE THAT COULD HAVE CAUSED THE REPORTED CONDITION. A FUNCTIONAL FLOW TEST WAS CONDUCTED AND FLOW CONTINUED WITHOUT STOPPING AT A NORMAL RATE UNTIL THE SOLUTION WAS EMPTIED FROM THE RESERVOIR. NO ROOT CAUSE WAS IDENTIFIED, AS NO EVIDENCE OF PRODUCT MALFUNCTION WAS OBSERVED. NO REPAIR WAS DONE, AS THIS IS A SINGLE-USE DEVICE WHICH WILL BE DISCARDED. NO OTHER OBSERVATIONS WERE NOTED ON THE UNIT. ADDITIONAL INFORMATION: THE BATCH REVIEW REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION.

Description of Event or Problem · 1

IT WAS REPORTED THAT AN INTERMATE "APPEARED TO HAVE CREATED A SECONDARY BALLOON WITHIN THE BOTTLE" AND STOPPED INFUSING DURING PATIENT THERAPY. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO REPORT OF PATIENT INJURY, MEDICAL INTERVENTION NECESSARY, OR ADVERSE REACTION IN ASSOCIATION WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
116089 INTERMATE PUMP, INFUSION FRN BAXTER HEALTHCARE - IRVINE 12E020

Patients

Seq Age Sex Outcome Treatment
1 PIP/TAZO 4.5 MG